Levels of Physical Activity and Sedentary Lifestyle in Patients With Hematological Cancer Treated With Monoclonal Antibodies as a Monotherapy or Combination Therapy (Immunochemotherapy): A Comparative Study With Healthy Individuals

07 June 2026 : Clinical Research

Małgorzata Pudełek^{BCDEF 1*}, Jarosław Dybko

^{E 1}, Iwona Malicka

^{ACDE 2}

DOI: 10.12659/MSM.952307

Med Sci Monit 2026; 32:e952307

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 6 Significance of the effect of clinical diagnosis on physical activity in the study groups.

	Kruskal-Wallis ANOVA					Cohen’s d
	P	D1 vs D5	D2 vs D5	D3 vs D5	D4 vs D5	Cohen’s d
Age 18–64 years
Intense activities (min/week)	0.0005^*	NS	0.01^*	NS	NS	0.619
Moderate activities (min/week)	0.0016^*	NS	NS	0.002^*	NS	0.564
Walking (min/week)	0.6029	NS	NS	NS	NS	0.167
Sitting (min/week)	<0.0001^*	0.02^*	<0.0001^*	<0.0001^*	<0.0001^*	1.308
Intense [MET]	0.0006^*	NS	0,01^*	NS	NS	0.609
Moderate [MET]	0.0017^*	NS	NS	0,002	NS	0.559
Walking [MET]	0.5641	NS	NS	NS	NS	0.151
IPAQ total MET	0.0010^*	NS	0.01^*	NS	NS	0.584
Age ≥65 years
Intense activities (min/week)	0.0770	NS	NS	NS	NS	0.44
Moderate activities (min/week)	0.1236	NS	NS	NS	NS	0.378
Walking (min/week)	0.7671	NS	NS	NS	NS	0.304
Sitting (min/week)	0.0001^*	0.01^*	0.0004^*	0.03^*	0.02^*	0.992
Intense [MET]	0.0578	NS	NS	NS	NS	0.47
Moderate [MET]	0.0802	NS	NS	NS	NS	0.43
Walking [MET]	0.8728	NS	NS	NS	NS	0.341
IPAQ total MET	0.6788	NS	NS	NS	NS	0.265
ANOVA – analysis of variance; D (diagnosis) 1–5: [1] leukemia, [2] myeloma, [3] Hodgkin’s disease, [4] lymphoma, [5] reference group; IPAQ – International Physical Activity Questionnaire; MET – metabolic equivalent of task; ^*

Back to the Article